Target intelligence / Profile preview

Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1)

Target
IL1RAPL1
Molecular classification
Receptor family (specifically, part of the interleukin-1 receptor family), Immunoglobulin superfamily protein
01

Overview

Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1) is a member of the interleukin-1 receptor family distinguished by its selective and high expression in the brain. Unlike canonical interleukin-1 receptor accessory proteins that mediate immune or inflammatory signaling, IL1RAPL1 does not participate in immune signaling but instead plays an essential role in nervous system development by organizing synapse formation and neuronal connectivity. Mutations or deletions in the IL1RAPL1 gene are causative for X-linked intellectual disability and may also contribute to neurodevelopmental disorders such as autism. The protein contains three immunoglobulin (Ig)-like domains in its extracellular region and is also known as Oligophrenin-4[2][6][7]. It mediates trans-synaptic cell adhesion and is critical for normal synaptic function and neural signaling in the human brain.

Other names
IL-1RAPL1IL1RAPL-1IL-1-RAPL-1Oligophrenin-4Three immunoglobulin domain-containing IL-1 receptor family member
02

Mechanism of action

Not applicable, as there are no drugs directly targeting this protein. Gene loss or mutation results in loss of function in neural synapse organization, but no targeted pharmacological mechanism is established[7].

03

Biological functions

Synapse formation and neural development (in the brain)Cell adhesion (in neurons)Neuronal signaling pathways (not classical immune signaling)
04

Disease associations

Neurodevelopmental disorders (especially X-linked intellectual disability and some forms of non-syndromic mental retardation)Other (potential involvement in autism spectrum disorders, as an area of ongoing research)
05

Safety considerations

Unintended effects on brain development and synaptic function if targeted

Beyond the preview

Go deeper on Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Interleukin-1 receptor accessory protein-like 1 (IL1RAPL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call